Genotyping of hepatitis C virus by the polymerase chain reaction: a comparison of two PCR-based methods using core or NS5 primers
スポンサーリンク
概要
著者
-
Chayama Kazuaki
Department Of Medicine And Molecular Science Graduate School Of Science Hiroshima University
-
Chayama Kazuaki
Hiroshima Univ. Hiroshima Jpn
-
Chayama K
Toranomon Hospital Tokyo Jpn
-
KOIDA Isao
Department of Gastroenterology, Toranomon Hospital
-
Koida Isao
Department Of Gastroenterology Toranomon Hospital
-
Chayama Kazuaki
First Department Of Internal Medicine Faculty Of Medicine Hiroshima University
-
Kobayashi M
Department Of Hepatology Toranomon Hospital
-
KOBAYASHI MARIKO
Liver Research Laboratory and Department of Gastroenterology, Toranomon Hospital
-
KUMADA HIROMITSU
Liver Research Laboratory and Department of Gastroenterology, Toranomon Hospital
-
KOIKE HIROMI
Liver Research Laboratory and Department of Gastroenterology, Toranomon Hospital
-
HASHIMOTO MICHIE
Liver Research Laboratory and Department of Gastroenterology, Toranomon Hospital
-
Hashimoto Michie
Department Of Liver Research Laboratory Toranomon Hospital
-
NAKANO Akemi
Liver Research Laboratory, Toranomon Hospital
-
TAKAGI Kimiko
Liver Research Laboratory, Toranomon Hospital
-
CHAYAMA Kazuaki
Okinaka Memorial Institute for Medical Research
-
TUBOTA Akihito
Okinaka Memorial Institute for Medical Research
-
KOIDA Isao
Okinaka Memorial Institute for Medical Research
-
SAITOH Satosi
Okinaka Memorial Institute for Medical Research
-
ARASE Yasuji
Okinaka Memorial Institute for Medical Research
-
IKEDA Kenji
Okinaka Memorial Institute for Medical Research
-
KANDA Masumi
Liver Research Laboratory, Department of Gastroenterology, Toranomon Hospital
-
IWASAKI Satomi
Liver Research Laboratory, Department of Gastroenterology, Toranomon Hospital
-
Nakano Akemi
Liver Research Laboratory Toranomon Hospital
-
Kanda Masumi
Liver Research Laboratory Department Of Gastroenterology Toranomon Hospital
-
Takagi Kimiko
Research Institute For Hepatology Toranomon Branch Hospital
-
Iwasaki Satomi
Liver Research Laboratory Department Of Gastroenterology Toranomon Hospital
-
Hashimoto Michie
Department Of Surgery Toranomon Hospital
-
Hashimoto Masashi
Department Of Surgery Toranomon Hospital
-
Hashimoto Masaji
Hepato Pancreato Billiary Surgery Unit Department Of Digestive Surgery Toranomon Hospital Tokyo
関連論文
- Efficacy of platinum analogue for advanced hepatocellular carcinoma unresponsive to transcatheter arterial chemoembolization with epirubicin
- Potential of laparoscopy in chronic liver disease with hepatitis B and C viruses
- Inhibitory effect of branched-chain amino acid granules on progression of compensated liver cirrhosis due to hepatitis C virus
- Factors associated with the virological response of lamivudine-resistant hepatitis B virus during combination therapy with adefovir dipivoxil plus lamivudine
- Interferon lowers tumor recurrence rate after surgical resection or ablation of hepatocellular carcinoma : a pilot study of patients with hepatitis B virus-related cirrhosis
- Efficacy of interferon monotherapy in young adult patients with chronic hepatitis C virus infection
- Cost-effectiveness of radiofrequency ablation and surgical therapy for small hepatocellular carcinoma of 3cm or less in diameter
- Adequate timing of ribavirin reduction in patients with hemolysis during combination therapy of interferon and ribavirin for chronic hepatitis C
- Efficacy of lamivudine treatment in Japanese patients with hepatitis B virus-related cirrhosis
- Efficacy of 6-month interferon therapy in chronic hepatitis B virus infection in Japan
- Infection with hepatitis B virus genotype A in Tokyo, Japan during 1976 through 2001
- Interferon monotherapy for patients with chronic hepatitis C and normal serum aminotransferase levels at commencement of treatment
- Factors contributing of ribavirin dose reduction due to anemia during interferon alfa2b and ribavirin combination therapy for chronic hepatitis C
- Peripheral CD8+/CD25+ lymphocytes may be implicated in hepatocellular injuries in patients with acute-onset autoimmune hepatitis
- Hepatocellular carcinoma in noncirrhotic young adult patients with chronic hepatitis B viral infection
- Efficacy of interferon retreatment after relapse for chronic hepatitis C patients with biochemical response after first interferon therapy
- Successful control of ruptured hepatocellular carcinoma with radiofrequency ablation
- Effectiveness of combination therapy of splenectomy and long-term interferon in patients with hepatitis C virus-related cirrhosis and thrombocytopenia
- Clinicopathological features, background liver disease, and survival analysis of HCV-positive patients with hepatocellular carcinoma : differences between young and elderly patients
- Changes in viral loads of lamivudine-resistant mutants during entecavir therapy
- Efficacy and anticarcinogenic activity of interferon for hepatitis C virus-related compensated cirrhosis in patients with genotype 1b low viral load or genotype 2
- Evaluation of long-term biochemical responses to combination therapy of interferon plus ribavirin in those infected with hepatitis C virus genotype 1b and high baseline viral load
- Efficacy of lamivudine therapy in elderly patients with chronic hepatitis B infection
- Type C-chronic hepatitis patients who had autoimmune phenomenon and developed jaundice during interferon therapy
- A randomized, double-blind, controlled trial of natural interferon-β therapy for e-antigen-negative chronic hepatitis B patients with abnormal transaminase levels
- High-dose interferon alpha-2b induction therapy in combination with ribavirin for Japanese patients infected with hepatitis C virus genotype 1b with a high baseline viral load
- Low rate of YMDD motif mutations in polymerase gene of hepatitis B virus in chronically infected patients not treated with lamivudine
- Usefulness of serum KL-6 for early diagnosis of idiopathic pulmonary fibrosis in patients with hepatitis C virus
- Screening of genes specifically activated in the pancreatic juice ductal cells from the patients with pancreatic ductal carcinoma
- Predictive values of amino acid sequences of the core and NS5A regions in antiviral therapy for hepatitis C : a Japanese multi-center study
- Expressions of Angiogenic Factors in Pancreatic Ductal Carcinoma : A Correlative Study with Clinicopathologic Parameters and Patient Survival
- Irsogladine Malate Up-regulates Gap Junctional Intercellular Communication Between Pancreatic Cancer Cells Via PKA Pathway
- Advanced glycation end products enhance the proliferation and activation of hepatic stellate cells
- A Nuclear Receptor-mediated Choleretic Action of Fibrates is Associated with Enhanced Canalicular Membrane Fluidity and Transporter Activity Mediating Bile Acid-independent Bile Secretion
- Partial characterization of cytoprotective mechanisms of lecithin against bile salt-induced bile duct damage
- Choleretic action of diosgenin is based upon the increases in canalicular membrane fluidity and transporter activity mediating bile acid independent bile flow
- Hydrophilic bile salts have a cytoprotective effect against cyclosporine A-induced cholestasis through enhanced canalicular membrane fluidity and transporter activity
- Matrix Metalloproteinases 9 Contributes to Human Atrial Structural Remodeling during Atrial Fibrillation
- Usefulness of hepatitis C virus RNA counts by second generation HCV bDNA-probe in chronic hepatitis C based on the HCV genotype
- Hepatitis G virus infection after blood transfusion in patients with chronic liver disease treated surgically for hepatocellular carcinoma
- Nucleotide sequences of hepatitis GB virus C. Identification of highly conserved domains in the 5' noncoding region and detection by polymerase chain reaction
- Effect of Sildenafil Citrate on Endothelial Function in Healthy Young Men
- Sodium Chloride Loading Does Not Alter Endothelium-Dependent Vasodilation of Forearm Vasculature in Either Salt-Sensitive or Salt-Resistant Patients with Essential Hypertenseion
- Randomized contolled clinical trial of lymphoblastoid interferon-α for chronic hepatitis C
- Incidence of the appearance of the red color sign on esophageal varices and its predictive factors : long-term observations of 359 patients with cirrhosis
- Twice-daily administration of interferon-beta for chronic hepatitis C is not superior to a once-daily regimen
- Interferon therapy for flare-up of hepatitis B virus infection after emergence of lamivudine-induced YMDD motif mutant
- Efficacy of IFN therapy based on duration period of negative HCV-RNA during IFN administration
- Distinction between chronic hepatitis and liver cirrhosis in patients with hepatitis C virus infection. Practical discriminant function using common laboratory data
- Progressive and sufficient decrease of hepatitis B core antibody can predict the disappearance of hepatitis B virus DNA in Japanese patients with hepatitis B surface antigen clearance
- Increased response rate to interferon therapy after a second course in hepatitis C patients who show relapse after the initial course
- Hepatic vascular side effects of styrene maleic acid neocarzinostatin in the treatment of hepatocellular carcinoma
- Fluctuation patterns of HCV-RNA serum level in patients with chronic hepatitis C
- A Device for Simultaneous Application of Sclerotherapy and Endoscopic Ligation for Management of Esophageal Varices
- Clinical and virological features of chronic hepatitis C carriers with normal alanine aminotransferase levels despite positive serum HCV-RNA after interferon therapy
- Enzyme-linked immunosorbent assay to detect hepatitis C virus serological groups 1 to 6
- Effect of arterial administration of a high-molecular weight antitumor agent, styrene maleic acid neocarzinostatin, in embolization-resistant liver cancer
- Efficacy and Changes of the Nonstructural 5A GENE by Prolonged Interferon Therapy for Patients with Hepatities C Virus genotype 1b and a High Level of Serum HCV-RNA
- Predictive value of different hepatitis C serological assays in the treatment of chronic hepatitis C with interferon α
- Glomerulonephritis in Autopsy Cases with Hepatitis C Virus Infection
- Relationship of hepatocellular carcinogenesis with precore mutant virus and serum hepatitis B virus DNA concentration A longitudinal analysis of patients with cirrhosis
- Detection of Hantaviral Antibodies among Patients with Hepatitis of Unknown Etiology in Japan
- ENDOSCOPIC DIAGNOSIS AND TREATMENT OF LOCAL RESIDUAL/RECURRENT LESIONS AFTER ENDOSCOPIC MUCOSAL RESECTION FOR EARLY COLORECTAL CARCINOMA
- Isolated granulomatous gastritis successfully treated by Helicobacter pylori eradication : a possible association between granulomatous gastritis and Helicobacter pylori
- Atorvastatin decreases serum levels of advanced glycation endproducts (AGEs) in nonalcoholic steatohepatitis (NASH) patients with dyslipidemia : clinical usefulness of AGEs as a biomarker for the attenuation of NASH
- Unique reciprocal changes of hepatocellular membrane transporter expression and fluidity in rats with selective biliary obstruction
- Effect of arterial administration of a high molecular weight anti-tumor agent, styrene maleic acid neocarzinostatin, for multiple small liver cancer - A pilot study
- The Superiority of Laparoscopic Examination in Predicting Hepatocellular Carcinoma after Inteferon Therapy for Chronic Type C Hepatitis
- Hepatitis C virus subtype 3b infection in a hospital Japan: Epidemiological study
- Typing six major hepatitis C virus genotypes by polymerase chain reaction using primers derived from nucleotide sequences of the NS5 region
- Novel Hepatitis B variants in sibling carriers postitive for antibody to hepatitis B surface antigen
- Genotyping of hepatitis C virus by the polymerase chain reaction: a comparison of two PCR-based methods using core or NS5 primers
- Usefulness of HCV-RNA counts by the method of HCV-bDNA probe in interferon retreatment for patients with HCV-RNA positive chronic hepatitis C
- A Pilot Study of Thymosin α_1 Therapy for Chronic Hepatitis B Patients
- Significance of multicentric cancer recurrence after potentially curative ablation of hepatocellular carcinoma : a longterm cohort study of 892 patients with viral cirrhosis
- Randomized trial of prolonged interferon retreatment for chronic hepatitis C patients with HCV-genotype 1b and high virus load
- Serum levels of γ-globulin and total bilirubin influence the prevalence of multiple extrahepatic complication in patients with hepatitis C virus infection
- Randomized, controlled trial of natural interferon-α therapy for e-antigen-positive chronic hepatitis B patients
- Clinical characteristics of patients infected with hepatitis B virus genotypes A, B, and C
- Development of HCC in patients receiving adefovir dipivoxil for lamivudine-resistant hepatitis B virus mutants
- Rapid loss of hepatitis C virus genotype 1b from serum in patients receiving a triple treatment with telaprevir (MP-424), pegylated interferon and ribavirin for 12 weeks
- Correlation of YMDD mutation and breakthrough hepatitis with hepatitis B virus DNA and serum ALT during lamivudine treatment
- Guidelines for the treatment of chronic hepatitis and cirrhosis due to hepatitis C virus infection for the fiscal year 2008 in Japan
- Guidelines for the treatment of chronic hepatitis and cirrhosis due to hepatitis B virus infection for the fiscal year 2008 in Japan
- Multivariate analysis of risk factors for the development of type 2 diabetes in nonalcoholic fatty liver disease
- Role of JNK in Thrombin-Induced ICAM-1 Expression in Endothelial Cells(Atherosclerosis, Basic 4 (IHD), The 69th Annual Scientific Meeting of the Japanese Circulation Society)
- In vitro-expanded hepatic progenitor cells-repopulated humanized mouse model for human HBV infection
- New classification of dynamic computed tomography images predictive of malignant characteristics of hepatocellular carcinoma
- Administration of interferon for two or more years decreases early stage hepatocellular carcinoma recurrence rate after radical ablation : A retrospective study of hepatitis C virus-related liver cancer
- Accumulation of refractory factors for pegylated interferon plus ribavirin therapy in older female patients with chronic hepatitis C
- Factors predictive of sustained virological response following 72 weeks of combination therapy for genotype 1b hepatitis C
- A simple clinical scoring system using ferritin, fasting insulin, and type IV collagen 7S for predicting steatohepatitis in nonalcoholic fatty liver disease
- Antiviral effects of peginterferon alpha-2b and ribavirin following 24-week monotherapy of telaprevir in Japanese hepatitis C patients
- Platelet count for predicting fibrosis in nonalcoholic fatty liver disease
- Prevalence and associated metabolic factors of nonalcoholic fatty liver disease in the general population from 2009 to 2010 in Japan : a multicenter large retrospective study
- Association between type 2 diabetes genetic susceptibility loci and visceral and subcutaneous fat area as determined by computed tomography
- Genetic variations in the CYP17A1 and NT5C2 genes are associated with a reduction in visceral and subcutaneous fat areas in Japanese women
- Computed tomography analysis of the association between the SH2B1 rs7498665 single-nucleotide polymorphism and visceral fat area
- Association of two polymorphisms of the IL28B gene with viral factors and treatment response in 1,518 patients infected with hepatitis C virus
- Impact of ribavirin dose reduction on the efficacy of pegylatecl interferon plus ribavirin combination therapy for elderly patients infected with genotype 1b and high viral loads